Price movement over the last 24 hours
Align Technology, Inc. vs Teucrium Soybean Fund — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Teucrium Soybean Fund trades at $25.24. The key difference: Teucrium Soybean Fund is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | SOYB | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $207.19 | $25.36 |
52-Week Low | $124.88 | $21.07 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
SOYB trades at $25.17, up 0.28% today, with a bullish technical outlook driven by strong moving average signals. The stock shows neutral oscillators but positive momentum from ADX. Recent news highlights potential tailwinds from China's $17 billion U.S. crop purchase pledge, which could benefit agricultural sector stocks. Financial ratios are unavailable in the provided data, limiting fundamental clarity.
The stock's outlook is supported by technical strength and positive sector sentiment, but lacks transparent fundamentals. Risks include reliance on agricultural market volatility and absent financial metrics. Investors should seek updated SEC filings for valuation context amid bullish technical indicators.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →